CIPOLLINI, MONICA
 Distribuzione geografica
Continente #
NA - Nord America 2.790
EU - Europa 1.124
AS - Asia 977
SA - Sud America 165
AF - Africa 44
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 5.103
Nazione #
US - Stati Uniti d'America 2.739
IT - Italia 425
CN - Cina 330
SG - Singapore 268
DE - Germania 191
HK - Hong Kong 156
BR - Brasile 146
SE - Svezia 122
GB - Regno Unito 80
BG - Bulgaria 71
VN - Vietnam 67
RU - Federazione Russa 55
FI - Finlandia 45
CA - Canada 40
IN - India 35
TR - Turchia 35
KR - Corea 28
EE - Estonia 24
UA - Ucraina 21
CI - Costa d'Avorio 19
FR - Francia 17
BE - Belgio 13
PL - Polonia 11
NL - Olanda 10
AR - Argentina 9
IQ - Iraq 9
AT - Austria 8
JP - Giappone 8
CH - Svizzera 7
CZ - Repubblica Ceca 7
MX - Messico 7
MA - Marocco 6
PK - Pakistan 6
BD - Bangladesh 5
ES - Italia 5
ID - Indonesia 5
SA - Arabia Saudita 5
SN - Senegal 5
DZ - Algeria 4
LT - Lituania 4
UZ - Uzbekistan 4
EC - Ecuador 3
OM - Oman 3
DO - Repubblica Dominicana 2
EG - Egitto 2
EU - Europa 2
GA - Gabon 2
JO - Giordania 2
KE - Kenya 2
LA - Repubblica Popolare Democratica del Laos 2
PY - Paraguay 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CM - Camerun 1
CR - Costa Rica 1
DK - Danimarca 1
GE - Georgia 1
GR - Grecia 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
IE - Irlanda 1
KG - Kirghizistan 1
ML - Mali 1
MY - Malesia 1
NP - Nepal 1
PE - Perù 1
PS - Palestinian Territory 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TG - Togo 1
TN - Tunisia 1
TW - Taiwan 1
VE - Venezuela 1
Totale 5.103
Città #
Ashburn 317
Fairfield 288
Woodbridge 273
Dallas 241
Ann Arbor 215
Houston 201
Chandler 156
Hong Kong 154
Santa Clara 145
Seattle 135
Serra 135
Cambridge 115
Singapore 105
Beijing 80
Wilmington 72
Sofia 70
Shanghai 66
Milan 63
New York 51
Pisa 38
Boardman 36
Princeton 36
Hefei 34
Munich 32
Los Angeles 31
Ottawa 30
Medford 26
Frankfurt am Main 25
London 25
Lawrence 24
Seoul 22
Abidjan 19
Des Moines 19
Florence 19
Dong Ket 18
Genoa 17
Ho Chi Minh City 14
Istanbul 14
Nanjing 14
Brussels 13
Buffalo 12
Lucca 12
Izmir 11
Lancaster 11
Phoenix 11
Jacksonville 10
Lappeenranta 10
Livorno 10
Redondo Beach 10
San Diego 10
Columbus 9
Dearborn 9
Nürnberg 9
Council Bluffs 8
Helsinki 8
Nettuno 8
The Dalles 8
Turku 8
Fuzhou 7
Nanchang 7
São Paulo 7
Tokyo 7
Viareggio 7
Warsaw 7
Bremen 6
Daejeon 6
Guangzhou 6
Pune 6
Rome 6
San Francisco 6
Shenyang 6
Vienna 6
Bern 5
Casablanca 5
Dakar 5
Ogden 5
Redwood City 5
Washington 5
Ankara 4
Belo Horizonte 4
Boulder 4
Brooklyn 4
Changsha 4
Düsseldorf 4
Falkenstein 4
Hanoi 4
Hyderabad 4
Islamabad 4
Nuremberg 4
Rio de Janeiro 4
Stockholm 4
Augusta 3
Chengdu 3
Falls Church 3
Goiânia 3
Las Vegas 3
Montreal 3
San Giuliano Terme 3
Shenzhen 3
Tashkent 3
Totale 3.761
Nome #
Expression status of candidate genes in mesothelioma tissues and cell lines 307
Polymorphisms within base and nucleotide excision repair pathways and risk of differentiated thyroid carcinoma 272
A common polymorphism within MSLN affects miR-611 binding site and soluble mesothelin levels in healthy people 252
Inhibition of the platelet-derived growth factor receptor beta (PDGFRB) using gene silencing, crenolanib besylate, or imatinib mesylate hampers the malignant phenotype of mesothelioma cell lines 228
Risk of Differentiated Thyroid Carcinoma and Polymorphisms within the Susceptibility Cancer Region 8q24 225
Mesothelin promoter variants are associated with increased soluble mesothelin-related peptide levels in asbestos-exposed individuals 210
Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism 198
Association between CYP2E1 polymorphisms and risk of differentiated thyroid carcinoma 195
A Drug Screening Revealed Novel Potential Agents against Malignant Pleural Mesothelioma 182
TPO genetic variants and risk of differentiated thyroid carcinoma in two European populations. 182
A comprehensive meta-analysis of case-control association studies to evaluate polymorphisms associated with the risk of differentiated thyroid carcinoma 177
Strategies for single base gene editing in an immortalized human cell line by CRISPR/Cas9 technology 176
Novel genome-wide association study-based candidate loci for differentiated thyroid cancer risk. 176
Bona fide targets of deregulated microRNAs in non-small cell lung cancer as tool to identify novel therapeutic targets. A review. 175
Inherited variants in genes somatically mutated in thyroid cancer 174
Polymorphisms within the RET proto-oncogene and risk of sporadic medullary thyroid carcinoma 173
Evidences that the polymorphism Pro-282-Ala within the tumor suppressor gene WWOX is a new risk factor for differentiated thyroid carcinoma 171
Genome-wide association study on differentiated thyroid cancer. 165
Risk of malignant pleural mesothelioma and polymorphisms in genes involved in the genome stability and xenobiotics metabolism 164
The polymorphism rs2480258 within CYP2E1 is associated with different rates of acrylamide metabolism in vivo in humans 159
Correction: Inherited variants in genes somatically mutated in thyroid cancer 155
Novel genetic variants in differentiated thyroid cancer and assessment of the cumulative risk 148
Pro64His (rs4644) polymorphism within galectin-3 is a risk factor of differentiated thyroid carcinoma and affects the transcriptome of thyrocytes engineered via CRISPR/Cas9 system 147
High prevalence of chromosome 10 rearrangements in human lymphocytes after in vitro X-ray irradiation 139
MicroRNA binding site polymorphisms as biomarkers in cancer management and research. 126
Runs of homozygosity and inbreeding in thyroid cancer 124
Drug-repositioning screening identified fludarabine and risedronic acid as potential therapeutic compounds for malignant pleural mesothelioma 120
Functional polymorphism within NUP210 encoding for nucleoporin GP210 is associated with the risk of endometriosis 109
Polymorphism Pro64His within galectin-3 has functional consequences at proteome level in thyroid cells 106
Variation rs2235503 C > A Within the Promoter of MSLN Affects Transcriptional Rate of Mesothelin and Plasmatic Levels of the Soluble Mesothelin-Related Peptide 97
null 17
Totale 5.249
Categoria #
all - tutte 14.253
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.253


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021248 0 0 0 0 22 14 21 22 42 23 26 78
2021/2022354 14 37 12 15 64 44 14 18 17 10 17 92
2022/2023472 44 78 29 43 42 66 3 43 77 3 41 3
2023/2024371 55 30 74 16 33 59 12 18 2 15 26 31
2024/20251.222 2 38 15 97 120 119 129 63 103 156 136 244
2025/2026678 138 194 198 104 44 0 0 0 0 0 0 0
Totale 5.249